Anemia severity and missed dialysis treatments in erythropoietin-treated hemodialysis patients

ASAIO Journal

Volumn 42, Issue 3, 1996, Pages 146-149

  Ifudu, Onyekachi ^a   Chan, Eva ^a   Paul, Henry ^a   Mayers, Joan D ^a   Cohen, Linda S ^a   Brezsnyak, William F ^b   Herman, Allen I ^b   Avram, Morrell M ^b   Friedman, Eli A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b Nephrology Foundation of Brooklyn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIALYSIS; HEMODIALYZERS; MATHEMATICAL MODELS; REGRESSION ANALYSIS;

ANEMIA SEVERITY; ERYTHROPOIETIN TREATMENT; MORBIDITY INDEX;

PATIENT TREATMENT;

ALBUMIN; CREATININE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE;

EID: 0030152940     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199605000-00005     Document Type: Article

References (27)

1. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305: 1176-1181, 1981.
2. Hartman E, Becker H: Noncompliance with prescribed regimens among chronic dialysis patients. Dial Transplant 7: 978-989, 1978.
3. Rocco MV, Burkart JM: Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 4: 1178-1183, 1993.
4. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990.
5. Charra B, Calemard E, Ruffet M, et al: Survival as an index of adequacy of dialysis. Kidney Inter 41: 1286-1291, 1992.
6. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MaCleod CM (ed), Evaluation of Chemotherapeutic Agents. New York, Columbia University Press, 1949, pp. 191-205.
7. Ifudu O, Paul H, Mayers JD, et al: Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 23: 394-400, 1994.
8. Ifudu O, Mayers JD, Cohen LS, et al: Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients. Am J Nephrol 16: 118-123, 1996.
9. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, et al: Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a phase III multicenter clinical trial. Ann Intern Med 111: 992-1000, 1989.
10. Eschbach JW: The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35: 134-148, 1989.
11. US Renal: Data System: USRDS 1992 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1992.
12. Rao SD, Shih M, Mohjni R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Wed 328: 171-175, 1993.
13. Braumann KM, Nonnast-Daniel B, Boning D, Bocker A, Frei U: Improved physical performance after treatment of renal anemia with recombinant human erythropoietin. Nephron 58: 129-134, 1991.
14. Wizemann V, Schafer R, Kramer W: Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left ventricular hypertrophy. Nephron 64: 202-206, 1993.
15. Ritz E, Zeier M, Schneider P, Jones E: Cardiovascular mortality of patients with polycystic kidney disease on dialysis: is there a lesson to learn? Nephron 66: 125-128, 1994.
16. Walcott DW, Maida CA, Diamond R, Nissenson AR: Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol 6: 329-338, 1986.
17. Morducchowicz G, Sulkes J, Aizic S, Gabbay U, Winkler J, Boner G: Compliance in hemodialysis patients: a multivariate regression analysis. Nephron 64: 365-368, 1993.
18. Simmens S, Kimmel PL, Kobrin S, Reiss D: Multidimensional assessment of compliance in two dialysis units. J Am Soc Nephrol 2: 351-357, 1991.
19. Martinez-Vea A, Garcia C, Gaya J, Rivera F, Oliver JA: Abnormalities of thirst regulation in patients with chronic renal failure on hemodialysis. Am J Nephrol 12: 73-79, 1992.
20. Jones R, Poston L, Hinestrosa H, Parsons V, Williams R: Weight gain between dialyses in diabetics: possible significance of raised intracellular sodium content. BMJ 280: 153, 1980.
21. Ifudu O, Pulin AL, Friedman EA: Interdialytic weight gain correlates with glycosylated hemoglobin in diabetic hemodialysis patients. Am J Kidney Dis 23: 686-691, 1994.
22. Iglehart JK: The American health care system-the end-stage renal disease program. N Engl J Med 328: 366-371, 1993.
23. Branche GC Jr, Batts JM, Dowdy VM, Field LS, Francis CK: Improving compliance in an inner-city hypertensive patient population. Am J Med 91: 37-41, 1991.
24. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts-overriding effects of HLA matching and socioeconomic factors. N Engl J Med 327: 840-845, 1992.
25. Shea S, Misra D, Ehrlich MH, Field L, Francis CK: Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 327: 776-781, 1992.
26. O'Brien ME: Compliance behavior and long-term maintenance dialysis. Am J Kidney Dis 15: 200-214, 1990.
27. Christensen AJ, Smith TW, Turner CW, Holman JM, Gregory MC, Rich MA: Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects. J Behav Med 15: 313-325, 1992.